📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-13 13:27
8 analysed today
FollowTelegram
8
Today
149,959
All-time analysed
42,990
Positive
6,669
Negative
91,590
Neutral
8,642
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1 announcement match the current filters (relevance ≥ 5).
Caprolactam Chemicals reports 81.7% YoY revenue drop and Rs 98.86 Lakhs net loss in Q1 FY27
Caprolactam Chemicals Ltd reported a severe downturn in its Q1 FY27 results, with revenue from operations plunging 81.7% YoY to just Rs 46.77 Lakhs. The company swung to a net loss of Rs 98.86 Lakhs for the quarter, compared to a profit of Rs 36.35 Lakhs in the same period last year. Total expenses of Rs 145.74 Lakhs significantly outpaced total income, driven by fixed costs like depreciation (Rs 36.71 Lakhs) and finance costs (Rs 17.76 Lakhs) which did not scale down with revenue. This performance represents a sharp reversal from the profitable FY26 trend.
Confidence: HIGH
What changedThe company transitioned from a profitable operation in FY26 to a significant loss-making position in Q1 FY27 due to a massive contraction in sales volume or realization.
Why it mattersFor a micro-cap company with a Rs 22 Cr market valuation, a quarterly loss of nearly Rs 1 Cr is material, representing approximately 4.5% of its entire market capitalization.
Revenue (Q1 FY27): Rs 46.77 LakhsNet Loss (Q1 FY27): Rs 98.86 LakhsYoY Revenue Growth: -81.7%Q1 Revenue vs TTM Revenue: ~4.3%Finance Costs: Rs 17.76 Lakhs
📅 Short termThe stock is likely to face significant downward pressure in the coming weeks as the market reacts to the sharp revenue decline and loss.
📈 Long termThe structural viability is concerning if the company cannot restore its quarterly revenue to the Rs 2.5-3.0 Cr range seen in previous quarters.
⚠ Risk flags
- Severe revenue contraction
- Operating expenses exceeding total income
- High finance costs relative to revenue
- Micro-cap liquidity risk
Key Highlights
Revenue from operations fell 81.7% YoY to Rs 46.77 Lakhs from Rs 256.47 Lakhs.
Net loss of Rs 98.86 Lakhs recorded against a profit of Rs 36.35 Lakhs in Q1 FY26.
Quarterly revenue represents only ~4.3% of the company's TTM revenue of Rs 11 Cr.
Earnings Per Share (EPS) dropped to -2.15 from 0.79 in the year-ago quarter.
Finance costs remained high at Rs 17.76 Lakhs, nearly 38% of the total quarterly revenue.
👀 What to Watch
Investors should investigate the cause of the sudden revenue collapse, such as potential plant shutdowns, supply chain disruptions, or loss of key customers, and monitor Q2 results for signs of recovery.
